Responding to a British Medical Journal report that new research has confirmed a long-understood increased risk of venous thromboembolism (VTE) in women taking the combined oral contraceptive pill, Dr Patricia Lohr, Medical Director of BPAS, said today
'This research simply adds to the medical evidence that the Pill is very safe medication, whichever brand women take. Media coverage of Pill risks must be kept in proportion with what the research actually says. We’d be worried if women were unnecessarily concerned by todays’ coverage.
'The absolute risk of suffering a venous thromboembolism (VTE) from any brand of the Pill is extremely low. We also know that the risk of suffering a VTE associated with pregnancy is higher than the risk while taking the Pill. So women who are very concerned about their VTE risk should not stop taking the Pill without considering the balance of risks involved.
'Our advice is that there’s no need for women who are happy with their current pill brand to switch on the basis of these findings. If women are considering switching Pills they should always speak to their doctor.’